Atropyn (When ATH S01FA01)

When ATH:
S01FA01

Characteristic.

Alkaloid, contained in plants of the nightshade family. The white crystalline or granular powder, soluble in water and alcohol.

Pharmacological action.
Holinoliticheskoe.

Application.

Ulcers disease of the stomach and duodenum, pilorospazm, cholelithiasis, intestinal cramps and urinary tract, ʙradiaritmii, for preoperative sedation, Poisoning means fosforotravlyayuschimi, When X-ray gastrointestinal, Fundus examination, to create a functional rest of inflammatory eye diseases and injuries, bronchial asthma, bronchitis with mucus overproduction.

Contraindications.

Hypersensitivity, glaucoma, obstructive bowel disease and urinary tract, paralytic ileus, toxic megacolon, yazvennыy colitis, hiatal hernia.

Pregnancy and breast-feeding.

Category actions result in FDA - C. (The study of reproduction in animals has revealed adverse effects on the fetus, and adequate and well-controlled studies in pregnant women have not held, However, the potential benefits, associated with drugs in pregnant, may justify its use, in spite of the possible risk.)

Side effects.

Xerostomia, midriaz, cycloplegia, tachycardia, atony bowel and bladder, headache, dizziness, Loss of touch.

Cooperation.

It reduces the effect of m-cholinomimetics and anticholinesterases.

Dosing and Administration.

B /, / m or n / a - By 1 ml 0,1% solution. Inside (before meals) — by 0.5-1 mg 1-2 times a day. In ophthalmology is by 1-2 drops 0,5 or 1% solution 2-6 times a day.